Florida Cancer Specialists & Research Institute (FCS) is seeking to reduce deaths and suffering from hereditary cancers with the launch of a cancer genetics program across its statewide practice. The use of a powerful and proven technology tool developed by Chicago-based software and data analytics company, CancerIQ, and the addition of a specially-trainedContinue Reading

Lucio Gordan, MD, President and Managing Physician of Florida Cancer Specialists Research & Institute (FCS), will lead an educational session at the Community Oncology Advocacy Summit, a national virtual meeting presented by the Community Oncology Alliance (COA). Scheduled for July 15, 2020, the one-day virtual conference will focus on patient advocacy and the impact ofContinue Reading

Florida Cancer Specialists & Research Institute (FCS) recently celebrated the start of construction of its new Trinity Cancer Center. When complete in early 2021, the 37,000 square foot facility will include radiation oncology and next-generation PET/CT imaging technology along with 27 exam rooms and 52 chairs for chemotherapy and other infusions.Continue Reading

Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the opening of a new office location in Middleburg, Florida on June 1, 2020. FCS currently has a clinic location in Fleming Island, making the Middleburg site its second location in the greater Jacksonville area.  Located at 1658 St. Vincent’s Way, Suite 340,Continue Reading

Despite the many challenges of the current health care crisis, patients of  Florida Cancer Specialists & Research Institute (FCS) report high satisfaction with the oncology provider’s response and efforts to provide care safely, and with little or no disruption.  In a survey of over 3,000 patients, conducted earlier this month by anContinue Reading

 Florida Cancer Specialists & Research Institute (FCS) offers an advanced radiation therapy option for several types of cancers, which can lead to faster and shorter rounds of radiation therapy for patients. Hypofractionated radiation is a treatment technique where the total dose of radiation is delivered in fewer treatment sessions and resultsContinue Reading

Florida Cancer Specialists & Research Institute (FCS) will expand access to comprehensive cancer treatment and opportunities for patients to participate in cutting-edge cancer research with the opening of its FCS Cancer Center and Sarah Cannon Research Institute Drug Development Unit in Lake Mary later this month. The newly constructed 25,000 square-footContinue Reading

Florida Cancer Specialists & Research Institute (FCS) and Cedar, a patient engagement and payment technology platform, today announced that they are partnering to modernize the on-line payment experience for FCS patients. “This partnership with Cedar enables us to keep pace with the rapid technology advances in the healthcare industry and improve theContinue Reading

Physicians and leaders of Florida Cancer Specialists & Research Institute (FCS) participated in the Florida Society of Clinical Oncology (FLASCO) Fall Session held in Orlando, Nov. 7 – 9.  The two-day statewide gathering of nearly 200 oncology physicians, clinicians and support staff featured dynamic educational presentations and case studies focused on colon cancer, multipleContinue Reading

Since its inception in 2011, the Florida Cancer Specialists (FCS) Foundation has provided over $5.5 million in grants to help cancer patients in need. The FCS Foundation has awarded $1.16 million in grants year-to-date in 2019, surpassing the prior year’s total. The FCS Foundation provides financial support to qualified adult cancer patients inContinue Reading

Florida Cancer Specialists Physician Recognized for Her Expertise and Leadership Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that FCS physician Dr. Faithlore Gardner has been appointed as a Session Chair for one of the Oral Abstract Sessions at the 2019 American Society of Clinical Oncology (ASCO)Annual Meeting, which will be held inContinue Reading

Dr. Andrew Lipman, who practices at Florida Cancer Specialists (FCS) in Bonita Springs and Naples West offices, was a co-author of a research paper evaluating the safety and efficacy of combining three drug agents – bendamustine, bortezomib and rituximab (BBR) – in patients with previously untreated low-grade lymphoma. Published January 2018 in the British Journal of Haematology,Continue Reading